Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 21, 2012

View Archived Issues

PaxVax presents phase I results on single-dose live oral cholera vaccine

A novel bispecific antibody shows tumor specificity in vivo

Lipoquin provides protection in murine model of pneumonic plague

Researchers at Bayer synthesize new cyclin-dependent kinase inhibitors

Oxford BioMedica provides update on ocular gene therapy candidates

FDA recommends continuation of Emmaus Medical's phase III sickle cell disease study

Astellas files sNDA for Tarceva in specific NSCLC subtype

European Commission approves Bayer's oral anticoagulant Xarelto for new indication

LEO Pharma's Picato gel receives European approval for actinic keratosis

Neovacs discloses final results from phase II TNF-alpha kinoid study

RNAi modifications: Progression from the bench to the clinic

Antisense morpholinos devised to treat spinal muscular atrophy

Dicerna's Dicer Substrate siRNA in lipid nanoparticles targets beta-catenin

Bayer Intellectual Property patents novel GCS activators

New C. difficile vaccines patented by Pfizer

GlaxoSmithKline synthesizes new bromodomain inhibitors

Ancora Pharmaceuticals presents new vaccines for Staphylococcus infection

New bispecific antibodies for cancer prepared by Genmab

Regen BioPharma begins preclinical study of HemaXellerate cell therapy

Atox Bio releases encouraging phase IIa topline results for AB-103

TMZ-POH has cytotoxic effects in temozolomide-resistant glioma cell lines

Preclinical study of H5N1 VLP vaccine shows cross-protection effects

European Commission approves Eliquis to prevent stroke in nonvalvular atrial fibrillation

Supernus' antiepileptic drug granted 3 years of market exclusivity in U.S.

XBiotech reports on interim analysis from phase II trial of monoclonal antibody

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...